Logo

American Heart Association

  47
  0


Final ID:

Beyond Antithrombotics: Lipid-Lowering and Anti-Inflammatory Therapies Post MI

  • Mehran, Roxana  ( Icahn School of Med. at Mount Sinai , New York , New York , United States )
  • Author Disclosures:
    Roxana Mehran: DO have relevant financial relationships ; Research Funding (PI or named investigator):Abbott, Alleviant Medical, Beth Israel Deaconess Medical Center, Concept Medical, CPC Clinical Research, Cordis, Elixir Medical, Faraday Pharmaceuticals, Idorsia Pharmaceuticals, Janssen, MedAlliance, Mediasphere Medical, Medtronic, Novartis, Protembis GmbH, RM Global Bioaccess Fund Management, Sanofi US Services, Inc.:Active (exists now) ; Other (please indicate in the box next to the company name):Honorarium: AMA - JAMA Cardiology (Associate Editor), ACC (BOT Member, SC Member CTR Program):Active (exists now) ; Other (please indicate in the box next to the company name):No Fees from: SCAI (Women in Innovations Committee Member), Faculty Cardiovascular Research Foundation (CRF), Women as One (Founding Director):Active (exists now) ; Individual Stocks/Stock Options:Elixir Medical, Stel, ControlRad (spouse):Active (exists now) ; Advisor:Elixir Medical, IQVIA, Medtronic, Medscape/WebMD Global, NovoNordisk:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

TCT at AHA: ACS/STEMI: What We Have Accomplished and Where We Are Going

Saturday, 11/08/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts from these authors:
SMART (primary results at ACC)

Mehran Roxana, Herrmann Howard

Presentation

Mehran Roxana, Barnes Geoffrey

You have to be authorized to contact abstract author. Please, Login
Not Available